Total Payments
$10,976
2024 Payments
$2,423
Companies
55
Transactions
710
Medicare Patients
4,668
Medicare Billing
$363,685
Payment Breakdown by Category
Food & Beverage$10,564 (96.2%)
Research$356.00 (3.2%)
Education$56.17 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,564 | 700 | 96.2% |
| Unspecified | $356.00 | 1 | 3.2% |
| Education | $56.17 | 9 | 0.5% |
Payments by Type
General
$10,620
709 transactions
Research
$356.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,366 | 101 | $0 (2024) |
| Novo Nordisk Inc | $988.73 | 65 | $0 (2024) |
| Amgen Inc. | $813.74 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $681.05 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $665.83 | 52 | $0 (2024) |
| Lilly USA, LLC | $642.83 | 48 | $0 (2024) |
| ABBVIE INC. | $490.12 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $487.33 | 38 | $0 (2024) |
| Allergan, Inc. | $474.51 | 11 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $463.03 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,423 | 137 | Novo Nordisk Inc ($416.02) |
| 2023 | $1,531 | 90 | Novo Nordisk Inc ($227.02) |
| 2022 | $706.71 | 39 | Amgen Inc. ($142.06) |
| 2020 | $222.88 | 15 | Allergan, Inc. ($34.48) |
| 2019 | $1,647 | 125 | PFIZER INC. ($243.22) |
| 2018 | $1,859 | 142 | PFIZER INC. ($262.22) |
| 2017 | $2,587 | 162 | Allergan Inc. ($422.65) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Obesity | ||||||
| 12/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.88 | General |
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Exact Sciences Corporation | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes Care | ||||||
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Obesity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 23, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION. | Allergan Inc. | $356.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,163 | 1,572 | $613,779 | $104,888 |
| 2022 | 18 | 1,058 | 1,300 | $448,626 | $91,566 |
| 2021 | 17 | 876 | 1,157 | $417,176 | $72,424 |
| 2020 | 30 | 1,571 | 2,138 | $544,958 | $94,807 |
Total Patients
4,668
Total Services
6,167
Medicare Billing
$363,685
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 647 | $271,093 | $40,635 | 15.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 294 | 294 | $132,300 | $35,805 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 71 | 87 | $51,417 | $8,539 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 208 | $56,069 | $5,986 | 10.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 37 | 45 | $27,675 | $4,670 | 16.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 28 | 51 | $12,393 | $1,807 | 14.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 13 | $13,286 | $1,537 | 11.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $11,312 | $1,442 | 12.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 19 | $10,982 | $1,294 | 11.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 113 | 113 | $7,345 | $988.75 | 13.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 23 | $10,656 | $941.21 | 8.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 25 | $4,631 | $836.38 | 18.1% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 12 | 12 | $3,276 | $287.47 | 8.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 19 | 21 | $1,344 | $118.75 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 284 | 284 | $116,156 | $35,789 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 390 | $95,756 | $15,919 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 176 | $67,012 | $10,389 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 71 | $37,972 | $7,184 | 18.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 42 | 48 | $26,832 | $5,253 | 19.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 20 | 20 | $13,300 | $3,232 | 24.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 21 | $21,462 | $3,125 | 14.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 41 | $15,840 | $2,257 | 14.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 38 | 46 | $10,166 | $1,708 | 16.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $5,448 | $1,567 | 28.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 21 | $11,025 | $1,487 | 13.5% |
About Dr. John Bertsch, MD
Dr. John Bertsch, MD is a Family Medicine healthcare provider based in Willoughby Hills, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326004334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Bertsch, MD has received a total of $10,976 in payments from pharmaceutical and medical device companies, with $2,423 received in 2024. These payments were reported across 710 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($10,564).
As a Medicare-enrolled provider, Bertsch has provided services to 4,668 Medicare beneficiaries, totaling 6,167 services with total Medicare billing of $363,685. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Willoughby Hills, OH
- Active Since 04/26/2006
- Last Updated 03/30/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326004334
Products in Payments
- ELIQUIS (Drug) $597.44
- CHANTIX (Drug) $517.06
- JARDIANCE (Drug) $364.65
- Ozempic (Drug) $345.39
- TRADJENTA (Drug) $266.84
- BEVESPI AEROSPHERE (Drug) $253.35
- EVENITY (Biological) $247.76
- Tymlos (Biological) $245.11
- FARXIGA (Drug) $244.82
- TOUJEO (Drug) $202.58
- EUCRISA (Drug) $200.17
- Prolia (Biological) $199.40
- Rybelsus (Drug) $190.89
- Myrbetriq (Drug) $185.23
- Cologuard Collection Kit (Device) $184.31
- FREESTYLE LIBRE 3 (Device) $176.13
- JANUVIA (Drug) $175.26
- UBRELVY (Drug) $165.62
- NURTEC ODT (Drug) $164.54
- Wegovy (Drug) $162.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Willoughby Hills
Sarah Gerhardstein, D.o, D.O
Family Medicine — Payments: $2,295
Family Medicine $2,295
Dr. Victor Bello, M.d, M.D
Family Medicine — Payments: $1,647
Family Medicine $1,647
Tara Tabbaa, Pa-C, PA-C
Family Medicine — Payments: $1,140
Family Medicine $1,140
Kaitlyn Simmonds, Md, MD
Family Medicine — Payments: $17.78
Family Medicine $17.78
Dr. Ye Zhu, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $13.00
Family Medicine $13.00